Alpha-Subunit

The Alpha-Subunit test measures the free alpha component shared by several glycoprotein hormones, including thyroid-stimulating hormone (TSH), luteinising hormone (LH), follicle-stimulating hormone (FSH) and human chorionic gonadotropin (hCG). Each of these hormones contains a common alpha subunit and a hormone-specific beta subunit. Normally, the two components combine to form an active hormone, but a small amount of free alpha subunit may also circulate in the blood.

Some pituitary tumours can produce excessive quantities of the free alpha subunit. Measurement may therefore support the evaluation of suspected pituitary adenomas, particularly TSH-secreting pituitary adenomas and some gonadotroph tumours. The test may also help doctors monitor a previously diagnosed tumour or evaluate response to surgery, medicine or other treatment. It is a specialized investigation and is not used as a routine screening test for the general population.

Benefits of the Test

• Measures the circulating free alpha subunit of glycoprotein hormones.
• Supports the investigation of selected functioning and non-functioning pituitary tumours.
• May help evaluate a suspected TSH-secreting pituitary adenoma.
• Provides supplementary information when thyroid results are clinically discordant.
• Can assist in monitoring tumour activity and response to treatment.
• May be interpreted with pituitary hormones, imaging and clinical findings.

Why Doctors Recommend This Test

An endocrinologist may recommend the Alpha-Subunit test when laboratory results suggest inappropriate pituitary hormone secretion. One important situation is an elevated free thyroxine or triiodothyronine level accompanied by a TSH result that is not appropriately suppressed. This pattern can occur with a rare TSH-secreting pituitary adenoma, also called a TSHoma. However, it can also occur because of thyroid hormone resistance, medicine effects, laboratory interference or other conditions, so alpha-subunit measurement is used as part of a broader evaluation.

The test may also be requested for patients with headaches, visual disturbances, menstrual irregularity, infertility, reduced sexual function, unexplained thyroid symptoms or other findings that raise concern about a pituitary mass. Some pituitary adenomas secrete free alpha subunit even when they do not produce an obvious clinical hormone syndrome. A previously diagnosed patient may undergo repeat testing to determine whether the level decreases after treatment or rises during follow-up.

Preparation Before Test

Fasting is generally not required unless other tests collected at the same time require it. Tell the doctor about pregnancy, menopause, hormone therapy, fertility medicines, thyroid medicines and all other medications or supplements. Physiological factors and medicines can influence related hormone concentrations and may affect interpretation. The doctor may specify a collection time or request that the test be performed with TSH, free T4, free T3, LH, FSH, hCG or other pituitary investigations. Do not stop any prescribed medication unless instructed by the treating doctor.

Normal Reporting Time

The Alpha-Subunit test is a specialized hormone assay and may require several working days or longer. The exact turnaround time depends on the testing schedule, sample transportation, laboratory method, quality-control procedures and whether repeat analysis is required. Focus Diagnostics will provide the applicable reporting estimate at the time of sample collection.

Who Should Take This Test?

• Patients undergoing evaluation for a suspected pituitary adenoma.
• People with elevated thyroid hormones and an inappropriately normal or elevated TSH result.
• Patients with symptoms or imaging findings suggestive of a pituitary mass.
• Individuals being evaluated for a possible TSH-secreting or gonadotroph pituitary tumour.
• Patients requiring follow-up after treatment for an alpha-subunit-secreting tumour.
• Anyone specifically advised to take the test by an endocrinologist or other specialist.

Detailed Information

TSH, LH, FSH and hCG are glycoprotein hormones formed from alpha and beta subunits. Their alpha components are structurally similar, whereas the beta component gives each hormone its biological specificity. Pituitary tumour cells may produce uncombined alpha subunits in excess, causing the blood concentration to rise. Nevertheless, an elevated result is not specific enough to diagnose a tumour by itself.

Alpha-subunit concentrations can vary with age, sex and reproductive status. Levels may be higher in postmenopausal individuals because gonadotropin production increases when ovarian function declines. Pregnancy and certain hormone-related conditions can also affect interpretation. Laboratories therefore apply method-specific reference intervals and may consider menopausal status or related hormone results. In suspected TSHoma, a specialist may calculate a molar alpha-subunit-to-TSH ratio, but this calculation requires appropriate units and expert interpretation.

A normal alpha-subunit level does not completely exclude a pituitary tumour because not every tumour releases a measurable excess. Likewise, a high result does not independently establish malignancy or prove the presence of an adenoma. Doctors may combine the result with thyroid function tests, other pituitary hormones, sex-hormone-binding globulin, dynamic endocrine testing, pituitary MRI and an ophthalmological visual-field examination.

If a pituitary adenoma is confirmed, management depends on its type, size, hormone activity and effects on surrounding structures. Options may include specialist monitoring, surgery, medication or radiotherapy. Serial alpha-subunit measurements should preferably be performed using the same laboratory method so changes can be interpreted consistently. All results must be reviewed by the treating specialist within the patient's complete endocrine and clinical context.